我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

单纯性肥胖症患者外周血ghrelin、obestatin的水平变化及其临床意义

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2009年第1期
页码:
95-98
栏目:
临床研究
出版日期:
2009-02-28

文章信息/Info

Title:
Study on circulating levels of ghrelin and obestatin in human simple obesity
作者:
徐海蓉12郑兴1郭志福1
1.第二军医大学长海医院心内科,上海 200433;2.武警新疆总队医院心内科,新疆 乌鲁木齐 830000
Author(s):
XU Hai-rong12 ZHENG Xing1 GUO Zhi-fu1
1.Department of Cardiovascular Diseases, Changhai Hospital, Second Military Medical University, Shanghai 200433, China; 2.Department of Cardiovascular Diseases, General Hospital, Xinjiang Armed Police Corps, Urumchi 830000, Xinjiang, China
关键词:
脑肠肽激素肥胖抑制素肥胖症
Keywords:
ghrelin obestatin obesity
分类号:
R587.1
DOI:
-
文献标识码:
A
摘要:
目的 探讨单纯性肥胖症患者餐前、餐后外周血肥胖抑制素(obestatin)水平的变化及其与ghrelin(一种脑肠肽激素)间的关系。方法 采用放射免疫法(RIA)检测16例单纯性肥胖症患者和14例正常对照者餐前1 h及其中各10例餐后2 h外周血ghrelin、obestatin水平;同时采用酶联免疫分析法(ELISA)检测餐前胰岛素水平并监测体质量指数(BMI)、腰臀比、血糖、血脂、白细胞及超敏C反应蛋白。结果 单纯性肥胖症患者餐前外周血ghrelin和obestatin水平均低于正常对照组(均P<0.01),但ghrelin/obestatin比值却明显高于正常对照组(P<0.01)。单纯性肥胖症组和正常对照组餐后ghrelin/obestatin比值均明显低于其餐前(分别P<0.05,P<0.01),但两组间差异无统计学意义。相关分析显示餐前ghrelin/obestatin比值与BMI(r=0.54,P<0.01)、腰围(r=0.39,P<0.05)、总胆固醇(r=0.40,P<0.05)和低密度脂蛋白胆固醇(r=0.41,P<0.05)呈正相关;与其它指标间相关性无统计学意义。结论 餐前外周血ghrelin、obestatin间比例失衡可能是单纯性肥胖症的发病机制之一。
Abstract:
AIM To investigate preprandial and postprandial changes of circulating ghrelin and obestatin levels in simple obesities. METHODS Plasma ghrelin and obestatin concentrations 1 hour before meal were measured by radioimmunoassay in 16 simple obese adolescents and 14 normal controls. Body mass index, waist-hip ratio, plasma glucose, plasma insulin, blood lipids, white blood cells count and high sensitive C-reactive protein were measured. Plasma ghrelin and obestatin concentrations 2 hours after meal were measured in 10 of the simple obese adolescents and 10 of the controls. RESULTS Although both prepramdial plasma ghrelin (P<0.01) and obestatin (P<0.05) concentrations decreased in simple obesities as compared with those in normal controls (both P<0.01), their ratios of ghrelin to obestatin were increased (P<0.01) even after adjustment for gender and age. The ratios of postprandial ghrelin to postprandial obestatin decreased both in simple obesities (P<0.05) and normal controls (P<0.01) compared with their preprandial ratios, but the postprandial ratios were similar between simple obesities and normal controls. There were significant positive correlations respectively between prepramdial ghrelin/obestatin and BMI (r=0.54, P<0.01), waist circumference (r=0.39, P<0.05), total cholesterol (r=0.40, P<0.05), low-density lipoprotein cholesterol (r=0.41, P<0.05). CONCLUSION The imbalance of prepramdial circulating ghrelin and obestatin may play a role in the pathogenesis of human obesity.

参考文献/References

[1] Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach[J]. Nature, 1999, 402(6762):656-660.
[2] Korbonits M, Goldstone AP, Gueorguiev M, et al. Ghrelin--a hormone with multiple functions[J]. Front Neuroendocrinol, 2004, 25(1):27-68.
[3] Kojima M, Kangawa K. Ghrelin: structure and function[J]. Physiol Rev, 2005, 85(2):495-522.
[4] van LA, Tschop M, Heiman ML, et al. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin[J]. Endocr Rev, 2004, 25(3):426-457.
[5] Zhang JV, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake[J]. Science, 2005, 310(5750):996-999.
[6] 中国肥胖问题工作组. 中国成人超重和肥胖症预防与控制指南(节录) [J]. 营养学报, 2004, 26(6):1-4.
[7] Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man[J]. Diabetologia, 1985, 28(7):412-419.
[8] Chanoine JP, Wong AC, Barrios V, et al. Obestatin, acylated and total ghrelin concentrations in the perinatal rat pancreas[J]. Horm Res, 2006, 66(5):81-88.
[9] Szentirmai E, Krueger JM. Obestatin alters sleep in rats[J]. Neurosci Lett, 2006, 404(1-2):222-226.

备注/Memo

备注/Memo:
收稿日期:2008-3-11.通讯作者:郑兴,主任医师,主要从事冠心病的治疗研究Email:XingZheng@126.com 作者简介:徐海蓉,副主任医师Email:ligang_xian@126.com
更新日期/Last Update: 2009-04-02